IP Library Granted Patent US 11,278,719
Granted Patent B2
US 11,278,719 · App. 16/363,256 · Granted Mar 22, 2022

Delivery of implantable neurostimulators

Inventors: Gur Oron (Tel Aviv, IL); Yossi Gross (Moshav Mazor, IL); Bar Eytan (Gedera, IL)
Assignee: BLUEWIND MEDICAL LTD.
A61N1/0558A61N1/0551A61N1/0556A61N1/36017A61N1/37205
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,278,719
App. No.
16/363,256
Granted
Mar 22, 2022
Kind
B2
Abstract

An electrostimulator implant includes an implant body, and at least two electrodes disposed on the implant body. The implant is percutaneously injectable into tissue of a subject with a distal portion of a flexible longitudinal member coupled to the implant. The apparatus is configured to be left, for at least 1 day after injection of the implant into the tissue, in a state in which (i) the implant is disposed within the tissue, (ii) the distal portion of the longitudinal member remains coupled to the implant within the tissue, (iii) a proximal portion of the longitudinal member is disposed outside of the tissue, secured to a skin surface of the subject, and (iv) the implant is movable within the tissue by moving the proximal portion of the longitudinal member. The longitudinal member is decouplable from the implant from outside of the subject. Other embodiments are also described.

Claims (18)

1. A method, comprising:

percutaneously injecting an implant into tissue of a subject, while a distal portion of a flexible longitudinal member is attached to the implant, the implant including an implant body and at least two electrodes disposed on the implant body;

subsequently, securing a proximal portion of the longitudinal member to a skin surface of the subject;

for at least 1 day after percutaneously injecting the implant, leaving:

the implant within the tissue, and

the proximal portion of the longitudinal member, outside of the tissue, secured to the skin surface; and

subsequently, by manipulating the longitudinal member from outside of the subject, detaching the distal portion of the longitudinal member from the implant.

2. The method according to claim 1 , further comprising moving the implant within the tissue by moving the proximal portion of the longitudinal member.

3. The method according to claim 1 , wherein:

injecting the implant into the tissue comprises injecting the implant via a tubular member into the tissue while a distal end of the tubular member is disposed within the tissue, and

the step of leaving comprises leaving:

the implant within the tissue,

a proximal portion of the tubular member disposed outside of the tissue, secured to the skin surface, and

the longitudinal member extending, from the implant, proximally through the tubular member and out of the subject.

4. The method according to claim 1 , wherein the longitudinal member includes a suture, and securing the proximal portion of the longitudinal member to the skin surface comprises securing a proximal portion of the suture to the skin surface.

5. The method according to claim 1 , wherein the longitudinal member includes a wire, and securing the proximal portion of the longitudinal member to the skin surface comprises securing a proximal portion of the wire to the skin surface.

6. The method according to claim 1 , wherein the implant is coupled to the distal portion of the longitudinal member by a lock, and detaching the distal portion of the longitudinal member from the implant comprises actuating the lock from outside of the subject.

7. The method according to claim 1 , wherein the longitudinal member is threaded through an eyelet defined by the implant, and detaching the distal portion of the longitudinal member from the implant comprises unthreading the longitudinal member from the eyelet.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2022
From: YOSSI GROSS; ORON, GURI; RONEN, SHLOMI; EYTAN, BAR; SOHN, ZEV; LORE, RAMI; NEEMAN, DANNY
To: BLUEWIND MEDICAL LTD.
Reel/Frame 059475/0741 →
Continuity (4)
Continuation 15860385 · Jan 2, 2018
Continuation 14649873
Provisional Application 61733995 · Dec 6, 2012
Related Publication 20190217085A1 · Jul 18, 2019